1.
dough
@semodough
BOOM
And here comes the 1st Biotech Buyout of 2023
$PRVB acquired by $SNF for $25 per share.
270% premium from… twitter.com/i/web/status/1…
And here comes the 1st Biotech Buyout of 2023
$PRVB acquired by $SNF for $25 per share.
270% premium from… twitter.com/i/web/status/1…
2.
dough
@semodough
$AUPH . Good weekend everyone
3.
4.
5.
6.
7.
dough
@semodough
$OCUL Ocular Therapeutix Reports Second Quarter 2021 Financial Results and Business Update | Ocular Therapeutix, I… twitter.com/i/web/status/1…
dough
@semodough
The Dessert sampler platter. Pretty sure this is down right sinful pic.twitter.com/cpSXoHMfMx
dough
@semodough
Piper Sandler/Raymond: Don’t Look Now, But Last Week Saw Biggest Biotech Inflows of the Year $XBI .
dough
@semodough
$ABOS #Alzheimers #IPO I don’t think people realize it’s out there. ?? RA capital led the last round November 2020. Some big in the name
dough
@semodough
$MYOV $PFE Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE, the First Once-Daily Treatment for Heav… twitter.com/i/web/status/1…
8.
9.
10.
11.
dough
@semodough
Tomorrow · MS 4/23, 2021: Curis $CRIS) Virtual NDR. Could we get another nugget lime we had at needham
dough
@semodough
EXCLUSIVE: The Oxford vaccine is expected to be approved within days of Christmas, kickstarting a massive drive t… twitter.com/i/web/status/1…
Retweet of status by @Telegraph
dough
@semodough
Piper $ALXO – CD47 is hot; $ALXO has only unencumbered CD47 asset left standing. $GILD $5B acquisition of $FTSV &… twitter.com/i/web/status/1…
dough
@semodough
$AMRN VASCEPA Data from REDUCE-IT REVASC, Including New Data on Timeframe to Demonstrated Benefit, Presented as E… twitter.com/i/web/status/1…
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
